Apelin receptors: From signaling to antidiabetic strategy

European Journal of Pharmacology

Volumn 763, Issue , 2015, Pages 149-159

  Chaves Almagro, C ^a   Castan Laurell, I ^a   Dray, C ^a   Knauf, C ^a   Valet, P ^a   Masri, B ^a  

^a INSERM   (France)

Author keywords

Adipokine; Apelin; APJ; Diabetes; Elabela; G protein coupled receptor; Metabolism; Obesity; Signaling; Toddler

Indexed keywords

APELIN; APELIN RECEPTOR; ANTIDIABETIC AGENT; G PROTEIN COUPLED RECEPTOR; SIGNAL PEPTIDE;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DISEASE ASSOCIATION; DOWN REGULATION; ENERGY METABOLISM; HUMAN; LIGAND BINDING; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OLIGOMERIZATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SIGNAL TRANSDUCTION; AMINO ACID SEQUENCE; ANIMAL; BLOOD; CHEMISTRY; DRUG EFFECTS; METABOLISM; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; ANIMALS; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; OBESITY; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84942367325     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.05.017     Document Type: Article

References (131)

1. K. Alexiadou, A. Kokkinos, S. Liatis, D. Perrea, N. Katsilambros, and N. Tentolouris Differences in plasma apelin and visfatin levels between patients with type 1 diabetes mellitus and healthy subjects and response after acute hyperglycemia and insulin administration Hormones (Athens) 11 2012 444 450
2. C. Alfarano, C. Foussal, O. Lairez, D. Calise, C. Attane, R. Anesia, D. Daviaud, E. Wanecq, A. Parini, P. Valet, and O. Kunduzova Transition from metabolic adaptation to maladaptation of the heart in obesity: role of apelin Int. J. Obes. (Lond.) 2014
3. C. Attane, D. Daviaud, C. Dray, R. Dusaulcy, M. Masseboeuf, D. Prevot, C. Carpene, I. Castan-Laurell, and P. Valet Apelin stimulates glucose uptake but not lipolysis in human adipose tissue ex vivo J. Mol. Endocrinol. 46 2011 21 28
4. C. Attane, C. Foussal, S. Le Gonidec, A. Benani, D. Daviaud, E. Wanecq, R. Guzman-Ruiz, C. Dray, V. Bezaire, C. Rancoule, K. Kuba, M. Ruiz-Gayo, T. Levade, J. Penninger, R. Burcelin, L. Penicaud, P. Valet, and I. Castan-Laurell Apelin treatment increases complete fatty acid oxidation, mitochondrial oxidative capacity, and biogenesis in muscle of insulin-resistant mice Diabetes 61 2012 310 320
5. Y. Audigier, L. Van den Berghe, and B. Masri Apelin signaling in retinal angiogenesis J.-J. Feige, G. Pagès, F. Soncin, Molecular Mechanisms of Angiogenesis - From Ontogenesis to Oncogenesis. 2014 Springer Paris 121 148
6. M. Azizi, X. Iturrioz, A. Blanchard, S. Peyrard, N. De Mota, N. Chartrel, H. Vaudry, P. Corvol, and C. Llorens-Cortes Reciprocal regulation of plasma apelin and vasopressin by osmotic stimuli J. Am. Soc. Nephrol. 19 2008 1015 1024
7. B. Bai, X. Cai, Y. Jiang, E. Karteris, and J. Chen Heterodimerization of apelin receptor and neurotensin receptor 1 induces phosphorylation of ERK(1/2) and cell proliferation via Galphaq-mediated mechanism J. Cell. Mol. Med. 18 2014 2071 2081
8. B. Bai, L. Liu, N. Zhang, C. Wang, Y. Jiang, and J. Chen Heterodimerization of human apelin and bradykinin 1 receptors: novel signal transduction characteristics Cell Signal. 26 2014 1549 1559
9. B. Bai, J. Tang, H. Liu, J. Chen, Y. Li, and W. Song Apelin-13 induces ERK1/2 but not p38 MAPK activation through coupling of the human apelin receptor to the Gi2 pathway Acta Biochim. Biophys. Sin. (Shanghai) 40 2008 311 318
10. G. Beaubien, M.K. Schafer, E. Weihe, W. Dong, M. Chretien, N.G. Seidah, and R. Day The distinct gene expression of the pro-hormone convertases in the rat heart suggests potential substrates Cell Tissue Res. 279 1995 539 549
11. J. Berta, M.A. Hoda, V. Laszlo, A. Rozsas, T. Garay, S. Torok, M. Grusch, W. Berger, S. Paku, F. Renyi-Vamos, G. Masri, W. Klepetko, B. Hegedus, and B. Dome Apelin promotes lymphangiogenesis and lymph node metastasis Oncotarget 5 2014 4426 4437
12. J. Berta, I. Kenessey, J. Dobos, J. Tovari, W. Klepetko, H. Jan Ankersmit, B. Hegedus, F. Renyi-Vamos, J. Varga, Z. Lorincz, S. Paku, G. Ostoros, A. Rozsas, J. Timar, and B. Dome Apelin expression in human non-small cell lung cancer: role in angiogenesis and prognosis J. Thorac. Oncol. 5 2010 1120 1129
13. C. Bertrand, A. Pignalosa, E. Wanecq, C. Rancoule, A. Batut, S. Deleruyelle, L. Lionetti, P. Valet, and I. Castan-Laurell Effects of dietary eicosapentaenoic acid (EPA) supplementation in high-fat fed mice on lipid metabolism and apelin/APJ system in skeletal muscle PLoS One 8 2013 e78874
14. A. Besse-Patin, E. Montastier, C. Vinel, I. Castan-Laurell, K. Louche, C. Dray, D. Daviaud, L. Mir, M.A. Marques, C. Thalamas, P. Valet, D. Langin, C. Moro, and N. Viguerie Effect of endurance training on skeletal muscle myokine expression in obese men: identification of apelin as a novel myokine Int. J. Obes. (Lond.) 38 2014 707 713
15. C. Bonnard, A. Durand, S. Peyrol, E. Chanseaume, M.A. Chauvin, B. Morio, H. Vidal, and J. Rieusset Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice J. Clin. Investig. 118 2008 789 800
16. J. Boucher, B. Masri, D. Daviaud, S. Gesta, C. Guigne, A. Mazzucotelli, I. Castan-Laurell, I. Tack, B. Knibiehler, C. Carpene, Y. Audigier, J.S. Saulnier-Blache, and P. Valet Apelin, a newly identified adipokine up-regulated by insulin and obesity Endocrinology 146 2005 1764 1771
17. I. Castan-Laurell, C. Dray, C. Attane, T. Duparc, C. Knauf, and P. Valet Apelin, diabetes, and obesity Endocrine 40 2011 1 9
18. I. Castan-Laurell, C. Dray, C. Knauf, O. Kunduzova, and P. Valet Apelin, a promising target for type 2 diabetes treatment? Trends Endocrinol. Metab. 23 2012 234 241
19. I. Castan-Laurell, M. Vitkova, D. Daviaud, C. Dray, M. Kovacikova, Z. Kovacova, J. Hejnova, V. Stich, and P. Valet Effect of hypocaloric diet-induced weight loss in obese women on plasma apelin and adipose tissue expression of apelin and APJ Eur. J. Endocrinol. 158 2008 905 910
20. M.G. Cavallo, F. Sentinelli, I. Barchetta, C. Costantino, M. Incani, L. Perra, D. Capoccia, S. Romeo, E. Cossu, F. Leonetti, L. Agati, and M.G. Baroni Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus PLoS One 7 2012 e51236
21. E. Ceraudo, C. Galanth, E. Carpentier, I. Banegas-Font, A.M. Schonegge, R. Alvear-Perez, X. Iturrioz, M. Bouvier, and C. Llorens-Cortes Biased signaling favoring gi over beta-arrestin promoted by an apelin fragment lacking the C-terminal phenylalanine J. Biol. Chem. 289 2014 24599 24610
22. N.A. Chapman, D.J. Dupre, and J.K. Rainey The apelin receptor: physiology, pathology, cell signalling, and ligand modulation of a peptide-activated class A GPCR Biochem. Cell. Biol. 92 2014 431 440
23. C. Charles The apelin peptides as putative targets in cardiovascular drug discovery and development Expert Opin. Drug Discov. 3 2008 51 64
24. X. Chen, B. Bai, Y. Tian, H. Du, and J. Chen Identification of serine 348 on the apelin receptor as a novel regulatory phosphorylation site in apelin-13-induced G protein-independent biased signaling J. Biol. Chem. 289 2014 31173 31187
25. S.C. Chng, L. Ho, J. Tian, and B. Reversade ELABELA: a hormone essential for heart development signals via the apelin receptor Dev. Cell 27 2013 672 680
26. H.J. Chun, Z.A. Ali, Y. Kojima, R.K. Kundu, A.Y. Sheikh, R. Agrawal, L. Zheng, N.J. Leeper, N.E. Pearl, A.J. Patterson, J.P. Anderson, P.S. Tsao, M.J. Lenardo, E.A. Ashley, and T. Quertermous Apelin signaling antagonizes Ang II effects in mouse models of atherosclerosis J. Clin. Investig. 118 2008 3343 3354
27. C.M. Cox, S.L. D'Agostino, M.K. Miller, R.L. Heimark, and P.A. Krieg Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo Dev. Biol. 296 2006 177 189
28. A. Cudnoch-Jedrzejewska, R. Gomolka, E. Szczepanska-Sadowska, K. Czarzasta, R. Wrzesien, L. Koperski, L. Puchalska, and A. Wsol High-fat diet and chronic stress reduce central pressor and tachycardic effects of apelin in Sprague-Dawley rats Clin. Exp. Pharmacol. Physiol. 42 2015 52 62
29. R.R. Cui, D.A. Mao, L. Yi, C. Wang, X.X. Zhang, H. Xie, X.P. Wu, X.B. Liao, H. Zhou, J.C. Meng, L.Q. Yuan, and E.Y. Liao Apelin suppresses apoptosis of human vascular smooth muscle cells via APJ/PI3-K/Akt signaling pathways Amino Acids 39 2010 1193 1200
30. C. D'Aniello, E. Lonardo, S. Iaconis, O. Guardiola, A.M. Liguoro, G.L. Liguori, M. Autiero, P. Carmeliet, and G. Minchiotti G protein-coupled receptor APJ and its ligand apelin act downstream of Cripto to specify embryonic stem cells toward the cardiac lineage through extracellular signal-regulated kinase/p70S6 kinase signaling pathway Circ. Res. 105 2009 231 238
31. N. De Mota, A. Reaux-Le Goazigo, S. El Messari, N. Chartrel, D. Roesch, C. Dujardin, C. Kordon, H. Vaudry, F. Moos, and C. Llorens-Cortes Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release Proc. Natl. Acad. Sci. USA 101 2004 10464 10469
32. E. Devic, L. Paquereau, P. Vernier, B. Knibiehler, and Y. Audigier Expression of a new G protein-coupled receptor X-msr is associated with an endothelial lineage in Xenopus laevis Mech. Dev. 59 1996 129 140
33. E. Devic, K. Rizzoti, S. Bodin, B. Knibiehler, and Y. Audigier Amino acid sequence and embryonic expression of msr/apj, the mouse homolog of Xenopus X-msr and human APJ Mech. Dev. 84 1999 199 203
34. C. Dray, C. Debard, J. Jager, E. Disse, D. Daviaud, P. Martin, C. Attane, E. Wanecq, C. Guigne, F. Bost, J.F. Tanti, M. Laville, H. Vidal, P. Valet, and I. Castan-Laurell Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans Am. J. Physiol. Endocrinol. Metab. 298 2010 E1161 E1169
35. C. Dray, C. Knauf, D. Daviaud, A. Waget, J. Boucher, M. Buleon, P.D. Cani, C. Attane, C. Guigne, C. Carpene, R. Burcelin, I. Castan-Laurell, and P. Valet Apelin stimulates glucose utilization in normal and obese insulin-resistant mice Cell Metab. 8 2008 437 445
36. C. Dray, Y. Sakar, C. Vinel, D. Daviaud, B. Masri, L. Garrigues, E. Wanecq, S. Galvani, A. Negre-Salvayre, L.S. Barak, B. Monsarrat, O. Burlet-Schiltz, P. Valet, I. Castan-Laurell, and R. Ducroc The intestinal glucose-apelin cycle controls carbohydrate absorption in mice Gastroenterology 144 2013 771 780
37. A. Drougard, T. Duparc, X. Brenachot, L. Carneiro, A. Gouaze, A. Fournel, L. Geurts, T. Cadoudal, A.C. Prats, L. Penicaud, D. Vieau, J. Lesage, C. Leloup, A. Benani, P.D. Cani, P. Valet, and C. Knauf Hypothalamic apelin/reactive oxygen species signaling controls hepatic glucose metabolism in the onset of diabetes Antioxid. Redox Signal. 20 2014 557 573
38. T. Duparc, A. Colom, P.D. Cani, N. Massaly, S. Rastrelli, A. Drougard, S. Le Gonidec, L. Mouledous, B. Frances, I. Leclercq, C. Llorens-Cortes, J.A. Pospisilik, N.M. Delzenne, P. Valet, I. Castan-Laurell, and C. Knauf Central apelin controls glucose homeostasis via a nitric oxide-dependent pathway in mice Antioxid. Redox Signal. 15 2011 1477 1496
39. S. El Messari, X. Iturrioz, C. Fassot, N. De Mota, D. Roesch, and C. Llorens-Cortes Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure J. Neurochem. 90 2004 1290 1301
40. G. Erdem, T. Dogru, I. Tasci, A. Sonmez, and S. Tapan Low plasma apelin levels in newly diagnosed type 2 diabetes mellitus Exp. Clin. Endocrinol. Diabetes 116 2008 289 292
41. X. Fan, N. Zhou, X. Zhang, M. Mukhtar, Z. Lu, J. Fang, G.C. DuBois, and R.J. Pomerantz Structural and functional study of the apelin-13 peptide, an endogenous ligand of the HIV-1 coreceptor, APJ Biochemistry 42 2003 10163 10168
42. S. Ferre, V. Casado, L.A. Devi, M. Filizola, R. Jockers, M.J. Lohse, G. Milligan, J.P. Pin, and X. Guitart G protein-coupled receptor oligomerization revisited: functional and pharmacological perspectives Pharmacol. Rev. 66 2014 413 434
43. G. Foldes, F. Horkay, I. Szokodi, O. Vuolteenaho, M. Ilves, K.A. Lindstedt, M. Mayranpaa, B. Sarman, L. Seres, R. Skoumal, Z. Lako-Futo, R. deChatel, H. Ruskoaho, and M. Toth Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure Biochem. Biophys. Res. Commun. 308 2003 480 485
44. C. Galanth, A. Hus-Citharel, B. Li, and C. Llorens-Cortes Apelin in the control of body fluid homeostasis and cardiovascular functions Curr. Pharm. Des. 18 2012 789 798
45. R. Gerbier, V. Leroux, P. Couvineau, R. Alvear-Perez, B. Maigret, C. Llorens-Cortes, and X. Iturrioz New structural insights into the apelin receptor: identification of key residues for apelin binding FASEB J. 29 2015 314 322
46. V.V. Gurevich, and E.V. Gurevich Extensive shape shifting underlies functional versatility of arrestins Curr. Opin. Cell Biol. 27 2014 1 9
47. Y. Habata, R. Fujii, M. Hosoya, S. Fukusumi, Y. Kawamata, S. Hinuma, C. Kitada, N. Nishizawa, S. Murosaki, T. Kurokawa, H. Onda, K. Tatemoto, and M. Fujino Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum Biochim. Biophys. Acta 1452 1999 25 35
48. M. Habchi, L. Duvillard, V. Cottet, M.C. Brindisi, B. Bouillet, M. Beacco, E. Crevisy, P. Buffier, S. Baillot-Rudoni, B. Verges, and J.M. Petit Circulating apelin is increased in patients with type 1 or type 2 diabetes and is associated with better glycaemic control Clin. Endocrinol. (Oxf.) 81 2014 696 701
49. R.W. Han, H.J. Xu, R.S. Zhang, and R. Wang The role of apelin-13 in novel object recognition memory Peptides 62 2014 155 158
50. M. Hosoya, Y. Kawamata, S. Fukusumi, R. Fujii, Y. Habata, S. Hinuma, C. Kitada, S. Honda, T. Kurokawa, H. Onda, O. Nishimura, and M. Fujino Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin J. Biol. Chem. 275 2000 21061 21067
51. X. Iturrioz, R. Alvear-Perez, N. De Mota, C. Franchet, F. Guillier, V. Leroux, H. Dabire, M. Le Jouan, H. Chabane, R. Gerbier, D. Bonnet, A. Berdeaux, B. Maigret, J.L. Galzi, M. Hibert, and C. Llorens-Cortes Identification and pharmacological properties of E339-3D6, the first nonpeptidic apelin receptor agonist FASEB J. 2009
52. X. Iturrioz, R. Gerbier, V. Leroux, R. Alvear-Perez, B. Maigret, and C. Llorens-Cortes By interacting with the C-terminal Phe of apelin, Phe255 and Trp259 in helix VI of the apelin receptor are critical for internalization J. Biol. Chem. 285 2010 32627 32637
53. S. Kagiyama, M. Fukuhara, K. Matsumura, Y. Lin, K. Fujii, and M. Iida Central and peripheral cardiovascular actions of apelin in conscious rats Regul. Pept. 125 2005 55 59
54. R.E. Kalin, M.P. Kretz, A.M. Meyer, A. Kispert, F.L. Heppner, and A.W. Brandli Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis Dev. Biol. 305 2007 599 614
55. D.S. Kang, X. Tian, and J.L. Benovic Role of beta-arrestins and arrestin domain-containing proteins in G protein-coupled receptor trafficking Curr. Opin. Cell Biol. 27 2014 63 71
56. Y. Kang, J. Kim, J.P. Anderson, J. Wu, S.R. Gleim, R.K. Kundu, D.L. McLean, J.D. Kim, H. Park, S.W. Jin, J. Hwa, T. Quertermous, and H.J. Chun Apelin-APJ signaling is a critical regulator of endothelial MEF2 activation in cardiovascular development Circ. Res. 113 2013 22 31
57. A. Kasai, Y. Ishimaru, T. Kinjo, T. Satooka, N. Matsumoto, Y. Yoshioka, A. Yamamuro, F. Gomi, N. Shintani, A. Baba, and S. Maeda Apelin is a crucial factor for hypoxia-induced retinal angiogenesis Arterioscler. Thromb. Vasc. Biol. 30 2010 2182 2187
58. A. Kasai, N. Shintani, H. Kato, S. Matsuda, F. Gomi, R. Haba, H. Hashimoto, M. Kakuda, Y. Tano, and A. Baba Retardation of retinal vascular development in apelin-deficient mice Arterioscler. Thromb. Vasc. Biol. 28 2008 1717 1722
59. Y. Kawamata, Y. Habata, S. Fukusumi, M. Hosoya, R. Fujii, S. Hinuma, N. Nishizawa, C. Kitada, H. Onda, O. Nishimura, and M. Fujino Molecular properties of apelin: tissue distribution and receptor binding Biochim. Biophys. Acta 1538 2001 162 171
60. T.R. Koves, J.R. Ussher, R.C. Noland, D. Slentz, M. Mosedale, O. Ilkayeva, J. Bain, R. Stevens, J.R. Dyck, C.B. Newgard, G.D. Lopaschuk, and D.M. Muoio Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance Cell Metab. 7 2008 45 56
61. J. Krist, K. Wieder, N. Kloting, A. Oberbach, S. Kralisch, T. Wiesner, M.R. Schon, D. Gartner, A. Dietrich, E. Shang, T. Lohmann, M. Dressler, M. Fasshauer, M. Stumvoll, and M. Bluher Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity Obes. Facts 6 2013 57 69
62. D.N. Langelaan, T. Reddy, A.W. Banks, G. Dellaire, D.J. Dupre, and J.K. Rainey Structural features of the apelin receptor N-terminal tail and first transmembrane segment implicated in ligand binding and receptor trafficking Biochim. Biophys. Acta 1828 2013 1471 1483
63. D.K. Lee, S.S. Ferguson, S.R. George, and B.F. O'Dowd The fate of the internalized apelin receptor is determined by different isoforms of apelin mediating differential interaction with beta-arrestin Biochem. Biophys. Res. Commun. 395 2010 185 189
64. D.K. Lee, V.R. Saldivia, T. Nguyen, R. Cheng, S.R. George, and B.F. O'Dowd Modification of the terminal residue of apelin-13 antagonizes its hypotensive action Endocrinology 146 2005 231 236
65. Y. Li, J. Chen, B. Bai, H. Du, Y. Liu, and H. Liu Heterodimerization of human apelin and kappa opioid receptors: roles in signal transduction Cell Signal. 24 2012 991 1001
66. F. Lin, H. Wu, H. Chen, Z. Xin, D. Yuan, T. Wang, J. Liu, Y. Gao, X. Zhang, C. Zhou, R. Wei, D. Chen, S. Yang, Y. Wang, Y. Pu, and Z. Li Molecular and physiological evidences for the role in appetite regulation of apelin and its receptor APJ in Ya-fish (Schizothorax prenanti) Mol. Cell. Endocrinol. 396 2014 46 57
67. C. Liu, T. Su, F. Li, L. Li, X. Qin, W. Pan, F. Feng, F. Chen, D. Liao, and L. Chen PI3K/Akt signaling transduction pathway is involved in rat vascular smooth muscle cell proliferation induced by apelin-13 Acta Biochim. Biophys. Sin. (Shanghai) 42 2010 396 402
68. Q. Liu, T. Hu, L. He, X. Huang, X. Tian, H. Zhang, W. Pu, L. Zhang, H. Sun, J. Fang, Y. Yu, S. Duan, C. Hu, L. Hui, T. Quertermous, Q. Xu, K. Red-Horse, J.D. Wythe, and B. Zhou Genetic targeting of sprouting angiogenesis using Apln-CreER Nat. Commun. 6 2015 6020
69. C. Llorens-Cortes, and F. Moos Opposite potentiality of hypothalamic coexpressed neuropeptides, apelin and vasopressin in maintaining body-fluid homeostasis Prog. Brain Res. 170 2008 559 570
70. S.Y. Lv, Y.J. Qin, H.T. Wang, N. Xu, Y.J. Yang, and Q. Chen Centrally administered apelin-13 induces depression-like behavior in mice Brain Res. Bull. 88 2012 574 580
71. S.Y. Lv, Y.J. Qin, N.B. Wang, Y.J. Yang, and Q. Chen Supraspinal antinociceptive effect of apelin-13 in a mouse visceral pain model Peptides 37 2012 165 170
72. S.Y. Lv, Y.J. Yang, and Q. Chen Regulation of feeding behavior, gastrointestinal function and fluid homeostasis by apelin Peptides 44 2013 87 92
73. S.Y. Lv, Y.J. Yang, Y.J. Qin, W. Xiong, and Q. Chen Effect of centrally administered apelin-13 on gastric emptying and gastrointestinal transit in mice Peptides 32 2011 978 982
74. W.Y. Ma, T.Y. Yu, J.N. Wei, C.S. Hung, M.S. Lin, Y.J. Liao, D. Pei, C.C. Su, K.C. Lu, P.H. Liu, C.H. Lin, L.M. Chuang, H.L. Kao, J.W. Lin, Y.J. Chuang, and H.Y. Li Plasma apelin: a novel biomarker for predicting diabetes Clin. Chim. Acta 435 2014 18 23
75. N.J. Macaluso, S.L. Pitkin, J.J. Maguire, A.P. Davenport, and R.C. Glen Discovery of a competitive apelin receptor (APJ) antagonist ChemMedChem 6 2011 1017 1023
76. J.J. Maguire, M.J. Kleinz, S.L. Pitkin, and A.P. Davenport [Pyr1]apelin-13 identified as the predominant apelin isoform in the human heart: vasoactive mechanisms and inotropic action in disease Hypertension 54 2009 598 604
77. P.R. Maloney, P. Khan, M. Hedrick, P. Gosalia, M. Milewski, L. Li, G.P. Roth, E. Sergienko, E. Suyama, E. Sugarman, K. Nguyen, A. Mehta, S. Vasile, Y. Su, D. Stonich, H. Nguyen, F.Y. Zeng, A.M. Novo, M. Vicchiarelli, J. Diwan, T.D. Chung, L.H. Smith, and A.B. Pinkerton Discovery of 4-oxo-6-((pyrimidin-2-ylthio)methyl)-4H-pyran-3-yl 4-nitrobenzoate (ML221) as a functional antagonist of the apelin (APJ) receptor Bioorg. Med. Chem. Lett. 22 2012 6656 6660
78. B. Masri, B. Knibiehler, and Y. Audigier Apelin signalling: a promising pathway from cloning to pharmacology Cell Signal. 17 2005 415 426
79. B. Masri, H. Lahlou, H. Mazarguil, B. Knibiehler, and Y. Audigier Apelin (65-77) activates extracellular signal-regulated kinases via a PTX-sensitive G protein Biochem. Biophys. Res. Commun. 290 2002 539 545
80. B. Masri, N. Morin, M. Cornu, B. Knibiehler, and Y. Audigier Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells FASEB J. 18 2004 1909 1911
81. B. Masri, N. Morin, L. Pedebernade, B. Knibiehler, and Y. Audigier The apelin receptor is coupled to Gi1 or Gi2 protein and is differentially desensitized by apelin fragments J. Biol. Chem. 281 2006 18317 18326
82. A.D. Medhurst, C.A. Jennings, M.J. Robbins, R.P. Davis, C. Ellis, K.Y. Winborn, K.W. Lawrie, G. Hervieu, G. Riley, J.E. Bolaky, N.C. Herrity, P. Murdock, and J.G. Darker Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin J. Neurochem. 84 2003 1162 1172
83. C. Mesmin, M. Dubois, F. Becher, F. Fenaille, and E. Ezan Liquid chromatography/tandem mass spectrometry assay for the absolute quantification of the expected circulating apelin peptides in human plasma Rapid Commun. Mass Spectrom. 24 2010 2875 2884
84. C. Mesmin, F. Fenaille, F. Becher, J.C. Tabet, and E. Ezan Identification and characterization of apelin peptides in bovine colostrum and milk by liquid chromatography-mass spectrometry J. Proteome Res. 10 2011 5222 5231
85. K.H. Miettinen, J. Magga, O. Vuolteenaho, E.J. Vanninen, K.R. Punnonen, K. Ylitalo, P. Tuomainen, and K.J. Peuhkurinen Utility of plasma apelin and other indices of cardiac dysfunction in the clinical assessment of patients with dilated cardiomyopathy Regul. Pept. 140 2007 178 184
86. S.J. Mihalik, B.H. Goodpaster, D.E. Kelley, D.H. Chace, J. Vockley, F.G. Toledo, and J.P. DeLany Increased levels of plasma acylcarnitines in obesity and type 2 diabetes and identification of a marker of glucolipotoxicity Obesity (Silver Spring) 18 2010 1695 1700
87. A.M. O'Carroll, S.J. Lolait, L.E. Harris, and G.R. Pope The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis J. Endocrinol. 219 2013 R13 R35
88. L.A. O'Donnell, A. Agrawal, P. Sabnekar, M.A. Dichter, D.R. Lynch, and D.L. Kolson Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury J. Neurochem. 102 2007 1905 1917
89. B.F. O'Dowd, M. Heiber, A. Chan, H.H. Heng, L.C. Tsui, J.L. Kennedy, X. Shi, A. Petronis, S.R. George, and T. Nguyen A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11 Gene 136 1993 355 360
90. A. Pauli, M.L. Norris, E. Valen, G.L. Chew, J.A. Gagnon, S. Zimmerman, A. Mitchell, J. Ma, J. Dubrulle, D. Reyon, S.Q. Tsai, J.K. Joung, A. Saghatelian, and A.F. Schier Toddler: an embryonic signal that promotes cell movement via Apelin receptors Science 343 2014 1248636
91. F.X. Picault, C. Chaves-Almagro, F. Projetti, H. Prats, B. Masri, and Y. Audigier Tumour co-expression of apelin and its receptor is the basis of an autocrine loop involved in the growth of colon adenocarcinomas Eur. J. Cancer 50 2014 663 674
92. A. Reaux-Le Goazigo, L. Bodineau, N. De Mota, L. Jeandel, N. Chartrel, C. Knauf, C. Raad, P. Valet, and C. Llorens-Cortes Apelin and the proopiomelanocortin system: a new regulatory pathway of hypothalamic alpha-MSH release Am. J. Physiol. Endocrinol. Metab. 301 2011 E955 E966
93. C. Ringstrom, M.D. Nitert, H. Bennet, M. Fex, P. Valet, J.F. Rehfeld, L. Friis-Hansen, and N. Wierup Apelin is a novel islet peptide Regul. Pept. 162 2010 44 51
94. A. Rivero-Muller, K.C. Jonas, A.C. Hanyaloglu, and I. Huhtaniemi Di/oligomerization of GPCRs - mechanisms and functional significance Prog. Mol. Biol. Transl. Sci. 117 2013 163 185
95. M. Saint-Geniez, B. Masri, F. Malecaze, B. Knibiehler, and Y. Audigier Expression of the murine msr/apj receptor and its ligand apelin is upregulated during formation of the retinal vessels Mech. Dev. 110 2002 183 186
96. A. Salahpour, and B. Masri Experimental challenge to a "rigorous" BRET analysis of GPCR oligomerization Nat. Methods 4 2007 599 600 (author reply 601)
97. M. Sawane, K. Kajiya, H. Kidoya, M. Takagi, F. Muramatsu, and N. Takakura Apelin inhibits diet-induced obesity by enhancing lymphatic and blood vessel integrity Diabetes 62 2013 1970 1980
98. R.C. Scarpulla Transcriptional paradigms in mammalian mitochondrial biogenesis and function Physiol. Rev. 88 2008 611 638
99. M.C. Scimia, C. Hurtado, S. Ray, S. Metzler, K. Wei, J. Wang, C.E. Woods, N.H. Purcell, D. Catalucci, T. Akasaka, O.F. Bueno, G.P. Vlasuk, P. Kaliman, R. Bodmer, L.H. Smith, E. Ashley, M. Mercola, J.H. Brown, and P. Ruiz-Lozano APJ acts as a dual receptor in cardiac hypertrophy Nature 488 2012 394 398
100. I.C. Scott, B. Masri, L.A. D'Amico, S.W. Jin, B. Jungblut, A.M. Wehman, H. Baier, Y. Audigier, and D.Y. Stainier The g protein-coupled receptor agtrl1b regulates early development of myocardial progenitors Dev. Cell 12 2007 403 413
101. K. Shin, A. Pandey, X.Q. Liu, Y. Anini, and J.K. Rainey Preferential apelin-13 production by the proprotein convertase PCSK3 is implicated in obesity FEBS Open Bio. 3 2013 328 333
102. K. Siddiquee, J. Hampton, D. McAnally, L. May, and L. Smith The apelin receptor inhibits the angiotensin II type 1 receptor via allosteric trans-inhibition Br. J. Pharmacol. 168 2013 1104 1117
103. M. Sorhede Winzell, C. Magnusson, and B. Ahren The apj receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice Regul. Pept. 131 2005 12 17
104. S.C. Sorli, S. Le Gonidec, B. Knibiehler, and Y. Audigier Apelin is a potent activator of tumour neoangiogenesis Oncogene 26 2007 7692 7699
105. S.C. Sorli, L. van den Berghe, B. Masri, B. Knibiehler, and Y. Audigier Therapeutic potential of interfering with apelin signalling Drug Discov. Today 11 2006 1100 1106
106. X. Sun, S. Iida, A. Yoshikawa, R. Senbonmatsu, K. Imanaka, K. Maruyama, S. Nishimura, T. Inagami, and T. Senbonmatsu Non-activated APJ suppresses the angiotensin II type 1 receptor, whereas apelin-activated APJ acts conversely Hypertens. Res. 34 2011 701 706
107. D. Sunter, A.K. Hewson, and S.L. Dickson Intracerebroventricular injection of apelin-13 reduces food intake in the rat Neurosci. Lett. 353 2003 1 4
108. I. Szokodi, P. Tavi, G. Foldes, S. Voutilainen-Myllyla, M. Ilves, H. Tokola, S. Pikkarainen, J. Piuhola, J. Rysa, M. Toth, and H. Ruskoaho Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility Circ. Res. 91 2002 434 440
109. S. Taheri, K. Murphy, M. Cohen, E. Sujkovic, A. Kennedy, W. Dhillo, C. Dakin, A. Sajedi, M. Ghatei, and S. Bloom The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats Biochem. Biophys. Res. Commun. 291 2002 1208 1212
110. S.Y. Tang, H. Xie, L.Q. Yuan, X.H. Luo, J. Huang, R.R. Cui, H.D. Zhou, X.P. Wu, and E.Y. Liao Apelin stimulates proliferation and suppresses apoptosis of mouse osteoblastic cell line MC3T3-E1 via JNK and PI3-K/Akt signaling pathways Peptides 28 2007 708 718
111. K. Tatemoto, M. Hosoya, Y. Habata, R. Fujii, T. Kakegawa, M.X. Zou, Y. Kawamata, S. Fukusumi, S. Hinuma, C. Kitada, T. Kurokawa, H. Onda, and M. Fujino Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor Biochem. Biophys. Res. Commun. 251 1998 471 476
112. K. Tatemoto, K. Takayama, M.X. Zou, I. Kumaki, W. Zhang, K. Kumano, and M. Fujimiya The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism Regul. Pept. 99 2001 87 92
113. G. Telegdy, and M. Jaszberenyi Transmitter mediation of the anxiolytic action of apelin-13 in male mice Behav. Brain Res. 263 2014 198 202
114. A. Than, Y. Cheng, L.C. Foh, M.K. Leow, S.C. Lim, Y.J. Chuah, Y. Kang, and P. Chen Apelin inhibits adipogenesis and lipolysis through distinct molecular pathways Mol. Cell. Endocrinol. 362 2012 227 241
115. C. Tiani, E. Garcia-Pras, A. MejiasM.,deGottardi, A. Berzigotti, J. Bosch, and M. Fernandez Apelin signaling modulates splanchnic angiogenesis and portosystemic collateral vessel formation in rats with portal hypertension J. Hepatol. 50 2008 296 305
116. A. Valle, N. Hoggard, A.C. Adams, P. Roca, and J.R. Speakman Chronic central administration of apelin-13 over 10 days increases food intake, body weight, locomotor activity and body temperature in C57BL/6 mice J. Neuroendocrinol. 20 2008 79 84
117. C. Vickers, P. Hales, V. Kaushik, L. Dick, J. Gavin, J. Tang, K. Godbout, T. Parsons, E. Baronas, F. Hsieh, S. Acton, M. Patane, A. Nichols, and P. Tummino Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase J. Biol. Chem. 277 2002 14838 14843
118. H. Xie, S.Y. Tang, R.R. Cui, J. Huang, X.H. Ren, L.Q. Yuan, Y. Lu, M. Yang, H.D. Zhou, X.P. Wu, X.H. Luo, and E.Y. Liao Apelin and its receptor are expressed in human osteoblasts Regul. Pept. 134 2006 118 125
119. H. Xie, L.Q. Yuan, X.H. Luo, J. Huang, R.R. Cui, L.J. Guo, H.D. Zhou, X.P. Wu, and E.Y. Liao Apelin suppresses apoptosis of human osteoblasts Apoptosis 12 2007 247 254
120. S. Xu, P. Han, M. Huang, J.C. Wu, C. Chang, P.S. Tsao, and P. Yue In vivo, ex vivo, and in vitro studies on apelin's effect on myocardial glucose uptake Peptides 37 2012 320 326
121. T. Yamamoto, Y. Habata, Y. Matsumoto, Y. Yasuhara, T. Hashimoto, H. Hamajyo, H. Anayama, R. Fujii, H. Fuse, Y. Shintani, and M. Mori Apelin-transgenic mice exhibit a resistance against diet-induced obesity by increasing vascular mass and mitochondrial biogenesis in skeletal muscle Biochim. Biophys. Acta 1810 2011 853 862
122. Y. Yang, X. Zhang, H. Cui, C. Zhang, C. Zhu, and L. Li Apelin-13 protects the brain against ischemia/reperfusion injury through activating PI3K/Akt and ERK1/2 signaling pathways Neurosci. Lett. 568 2014 44 49
123. P. Yue, H. Jin, M. Aillaud, A.C. Deng, J. Azuma, T. Asagami, R.K. Kundu, G.M. Reaven, T. Quertermous, and P.S. Tsao Apelin is necessary for the maintenance of insulin sensitivity Am. J. Physiol. Endocrinol. Metab. 298 2010 E59 E67
124. P. Yue, H. Jin, S. Xu, M. Aillaud, A.C. Deng, J. Azuma, R.K. Kundu, G.M. Reaven, T. Quertermous, and P.S. Tsao Apelin decreases lipolysis via G(q), G(i), and AMPK-dependent mechanisms Endocrinology 152 2011 59 68
125. X.J. Zeng, S.P. Yu, L. Zhang, and L. Wei Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons Exp. Cell Res. 316 2010 1773 1783
126. X.X. Zeng, T.P. Wilm, D.S. Sepich, and L. Solnica-Krezel Apelin and its receptor control heart field formation during zebrafish gastrulation Dev. Cell 12 2007 391 402
127. Y. Zhang, C. Shen, X. Li, G. Ren, X. Fan, F. Ren, N. Zhang, J. Sun, and J. Yang Low plasma apelin in newly diagnosed type 2 diabetes in Chinese people Diabetes Care 32 2009 e150
128. E.Y. Zhen, R.E. Higgs, and J.A. Gutierrez Pyroglutamyl apelin-13 identified as the major apelin isoform in human plasma Anal. Biochem. 442 2013 1 9
129. N. Zhou, J. Fang, E. Acheampong, M. Mukhtar, and R.J. Pomerantz Binding of ALX40-4C to APJ, a CNS-based receptor, inhibits its utilization as a co-receptor by HIV-1 Virology 312 2003 196 203
130. N. Zhou, X. Zhang, X. Fan, E. Argyris, J. Fang, E. Acheampong, G.C. DuBois, and R.J. Pomerantz The N-terminal domain of APJ, a CNS-based coreceptor for HIV-1, is essential for its receptor function and coreceptor activity Virology 317 2003 84 94
131. S. Zhu, F. Sun, W. Li, Y. Cao, C. Wang, Y. Wang, D. Liang, R. Zhang, S. Zhang, H. Wang, and F. Cao Apelin stimulates glucose uptake through the PI3K/Akt pathway and improves insulin resistance in 3T3-L1 adipocytes Mol. Cell. Biochem. 353 2011 305 313